↓ Skip to main content

Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events

Overview of attention for article published in Cochrane database of systematic reviews, March 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
5 tweeters

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
108 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events
Published in
Cochrane database of systematic reviews, March 2012
DOI 10.1002/14651858.cd007695.pub3
Pubmed ID
Authors

Christopher J Cates, Toby J Lasserson

Abstract

An increase in serious adverse events with both regular formoterol and regular salmeterol in chronic asthma has been demonstrated in previous Cochrane reviews.

Twitter Demographics

The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 108 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 2%
Colombia 1 <1%
Germany 1 <1%
Unknown 104 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 16 15%
Researcher 16 15%
Student > Ph. D. Student 12 11%
Student > Bachelor 11 10%
Other 11 10%
Other 21 19%
Unknown 21 19%
Readers by discipline Count As %
Medicine and Dentistry 51 47%
Nursing and Health Professions 9 8%
Social Sciences 7 6%
Psychology 4 4%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Other 7 6%
Unknown 26 24%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 November 2020.
All research outputs
#9,896,941
of 16,975,484 outputs
Outputs from Cochrane database of systematic reviews
#9,427
of 11,600 outputs
Outputs of similar age
#69,677
of 129,816 outputs
Outputs of similar age from Cochrane database of systematic reviews
#88
of 117 outputs
Altmetric has tracked 16,975,484 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,600 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 24.5. This one is in the 17th percentile – i.e., 17% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 129,816 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 117 others from the same source and published within six weeks on either side of this one. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.